Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

• Susan Kühnast ,

  Contributed equally to this work with: Susan Kühnast, Mieke C. Louwe

  * E-mail: susan.jordaan@tno.nl

  Affiliations TNO - Metabolic Health Research, Leiden, The Netherlands, Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Mieke C. Louwe ,

  Contributed equally to this work with: Susan Kühnast, Mieke C. Louwe

  Affiliations Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Mattijs M. Heemskerk,

  Affiliations Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Elsbet J. Pieterman,

  Affiliation TNO - Metabolic Health Research, Leiden, The Netherlands

  ⨯
• Jan B. van Klinken,

  Affiliations Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Sjoerd A. A. van den Berg,

  Affiliations Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Johannes W. A. Smit,

  Affiliations Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Louis M. Havekes,

  Affiliations TNO - Metabolic Health Research, Leiden, The Netherlands, Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Patrick C. N. Rensen,

  Affiliations Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• José W. A. van der Hoorn,

  Affiliations TNO - Metabolic Health Research, Leiden, The Netherlands, Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Hans M. G. Princen ,

  ¶These authors also contributed equally to this work.

  Affiliation TNO - Metabolic Health Research, Leiden, The Netherlands

  ⨯
• J. Wouter Jukema

  ¶These authors also contributed equally to this work.

  Affiliations Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯